Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin

References

• Acocella G, Bertrand A, Beytout J, et al. Comparison of three different regimens in the treatment of acute brucellosis: A multinational study. Journal of Antimicrobial Agents Chemotherapy 1989; 23: 433–439
   PubMed Web of Science ®Google Scholar
• Ahsan F, Rivas IP, Khan MA, et al. Targeting to macrophages: Role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. Journal of Controlled Release 2002; 79: 29–40
   PubMed Web of Science ®Google Scholar
• Ariza J, Gudiol F, Pallares R, et al. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double–blind study. Annals of Internal Medicine 1992; 117: 25–30
   PubMed Web of Science ®Google Scholar
• Bayindir Y, Sonmez E, Aladag A, et al. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: A prospective, randomized study. Journal of Chemotherapy 2003; 15: 466–471
   PubMed Web of Science ®Google Scholar
• Blanco-Prieto M, Lecaroz C, Renedo M, et al. In vitro evaluation of gentamicin released from microparticles. International Journal of Pharmaceutics 2002; 242: 203–206
   PubMed Web of Science ®Google Scholar
• Celli J. Surviving inside a macrophage: The many ways of Brucella. Research in Microbiology 2005; 157: 93–98
   PubMed Web of Science ®Google Scholar
• Chatterjee SS, Hossain H, Otten S, et al. Intracellular gene expression profile of listeria monocytogenes. Infection and Immunity 2006; 74: 1323–1338
   PubMed Web of Science ®Google Scholar
• Dees C, Fountain MW, Taylor JR, et al. Enhanced intraphagocytic killing of Brucella abortus in bovine mononuclear cells by liposomes-containing gentamicin. Veterinary Immunology and Immunopathology 1985; 8: 171–182
   PubMed Web of Science ®Google Scholar
• Dutt M, Khuller GK. Therapeutic efficacy of poly (DL-lactide-co-glycolide)-encapsulated antitubercular drugs against mycobacterium tuberculosis infecion induced in mice. Antimicrobial Agents Chemotherapy 2001; 45: 363–366
   PubMed Web of Science ®Google Scholar
• Evora C, Soriano I, Rogers RA, et al. Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: The effect of 1,2-dipalmitoylphosphatidylcholine. Journal of Controlled Release 1998; 51: 143–152
   PubMed Web of Science ®Google Scholar
• Gorvel JP, Moreno E. Brucella intracellular life: From invasion to intracellular replication. Veterinary Microbiology 2002; 90: 281–297
   PubMed Web of Science ®Google Scholar
• Hernandez-Caselles T, Vera A, Crespo F, et al. Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin. American Journal of Veterinary Research 1989; 50: 1486–1488
   PubMed Web of Science ®Google Scholar
• Kostanski JW, Dani BA, Reynolds GA, et al. Evaluation of Orntide microspheres in a rat animal model and correlation to in vitro release profiles. American Association of Pharmaceutical Scientists, Pharmaceutical Science Technology 2000; 1: E27
   Google Scholar
• Mortensen JE, Moore DG, Clarridge JE, et al. Antimicrobial susceptibility of clinical isolates of Brucella. Diagnostic Microbiology and Infectious Disease 1986; 5: 163–169
   PubMed Web of Science ®Google Scholar
• Müller RH, Rühl D, Lück M, et al. Influence of fluorescent labelling of polyestyrene particles on phagocyte uptake, surface hydrophobicity and plasma protein adsorption. Pharmaceutical Research 1997; 14: 18–24
   PubMed Web of Science ®Google Scholar
• Naraharisetti PK, Lew MD, Fu YC, et al. Gentamicin-loaded discs and microspheres and their modifications: Characterization and in vitro release. Journal of Controlled Release 2005; 102: 345–359
   PubMed Web of Science ®Google Scholar
• Nguyen L, Pieters J. The Trojan horse: Survival tactics of pathogenic mycobacteria in macrophages. Trends in Cell Biology 2005; 15: 269–276
   PubMed Web of Science ®Google Scholar
• O’Brien CN, Guidry AJ. Formulation of poly(D,L-lactide-co-glycolide) microspheres and their ingestion y bovine leukocytes. Journal of Dayri Science 1996; 79: 1954–1959
   PubMed Web of Science ®Google Scholar
• Pappas G, Solera J, Akritidis N, et al. New approaches to the antibiotic treatment of brucellosis. International Journal of Antimicrobial Agents 2005; 26: 101–105
   PubMed Web of Science ®Google Scholar
• Prior S, Gamazo C, Irache JM, et al. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. International Journal of Pharmaceutics 2000; 196: 115–125
   PubMed Web of Science ®Google Scholar
• Prior S, Gander B, Blarer N, et al. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. European Journal of Pharmaceutical Sciences 2002; 15: 197–207
   PubMed Web of Science ®Google Scholar
• Prior S, Gander B, Lecaroz C, et al. Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. Journal of Antimicrobial Chemotherapy 2004; 53: 981–988
   PubMed Web of Science ®Google Scholar
• Prior S, Gander B, Irache JM, et al. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. Journal of Antimicrobial Chemotherapy 2005; 55: 1032–1036
   PubMed Web of Science ®Google Scholar
• Quenelle DC, Staas JK, Winchester GA, et al. Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice. Antimicrobial Agents Chemotherapy 1999; 43: 1144–1151
   PubMed Web of Science ®Google Scholar
• Quenelle DC, Winchester GA, Staas JK, et al. Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid. Antimicrobial Agents Chemotherapy 2001; 45: 1637–1644
   PubMed Web of Science ®Google Scholar
• Rolain JM, Maurin M, Raoult D. Bactericidal effect of antibiotics on Bartonella and Brucella spp.: Clinical implications. Journal of Antimicrobial Chemotherapy 2000; 46: 811–814
   PubMed Web of Science ®Google Scholar
• Rudt S, Müller RH. In vitro phagocytosis assay of nano- and microparticles by chemiluminiscence. I: Effect of analytical parameters, particle size and particle concentration. Journal of Controlled Release 1992; 22: 263–272
   Web of Science ®Google Scholar
• Schieffelers R, Storm G, Bakker-Woudenberg I. Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models. International Journal of Pharmaceutics 2001; 214: 103–105
   PubMed Web of Science ®Google Scholar
• Solera J, Geijo P, Largo J, et al. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clinical Infectious Diseases 2004; 39: 1776–1782
   PubMed Web of Science ®Google Scholar
• Swenson CE, Stewart KA, Hammett JL, et al. Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin. Antimicrobial Agents Chemotherapy 1990; 34: 235–240
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Phagocytosis of polymeric microspheres. High performance biomaterials, M Szycher. Technomic Publishing Com. Inc, Lancaster, PA 1991; 621–646
   Google Scholar
• Thomasin C, Corradin G, Men Y, et al. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response. Journal of Controlled Release 1996; 41: 131–145
   Web of Science ®Google Scholar
• Vitas AI, Diaz R, Gamazo C. Protective effect of liposomal gentamicin against systemic acute murine brucellosis. Chemotherapy 1997; 43: 204–210
   PubMed Web of Science ®Google Scholar
• World Health Organization. FAO-WHO expert committee on Brucellosis. WHO technical report. 6th report. World Health Organization, Geneva 1986, Report no. 740
   Google Scholar
• Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerging Infectious Diseases 2005; 11: 1180–1185
   PubMed Web of Science ®Google Scholar
• Young EJ. An overview of human brucellosis. Clinical Infectious Diseases 1995; 21: 283–289, quiz 290
   PubMed Web of Science ®Google Scholar